| __timestamp | Merck & Co., Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 42237000000 | 28203205 |
| Thursday, January 1, 2015 | 39498000000 | 99892000 |
| Friday, January 1, 2016 | 39807000000 | 133591000 |
| Sunday, January 1, 2017 | 40122000000 | 154937000 |
| Monday, January 1, 2018 | 42294000000 | 164246000 |
| Tuesday, January 1, 2019 | 46840000000 | 175338000 |
| Wednesday, January 1, 2020 | 41518000000 | 198321000 |
| Friday, January 1, 2021 | 48704000000 | 227490000 |
| Saturday, January 1, 2022 | 59283000000 | 212018000 |
| Sunday, January 1, 2023 | 60115000000 | 145238000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, revenue is a key indicator of success. Over the past decade, Merck & Co., Inc. has consistently outperformed Travere Therapeutics, Inc. in terms of annual revenue. From 2014 to 2023, Merck's revenue surged by approximately 42%, peaking at $60 billion in 2023. In contrast, Travere's revenue, while growing, remains modest, reaching just over $227 million at its highest in 2021. This stark difference highlights Merck's dominant market position, with revenues nearly 265 times greater than Travere's in 2023. The data underscores Merck's robust growth trajectory and market leadership, while Travere continues to carve its niche in the industry. As the pharmaceutical sector evolves, these revenue trends offer a glimpse into the strategic positioning and potential future directions of these two companies.
Johnson & Johnson and Merck & Co., Inc.: A Comprehensive Revenue Analysis
Breaking Down Revenue Trends: Merck & Co., Inc. vs Teva Pharmaceutical Industries Limited
Comparing Revenue Performance: Merck & Co., Inc. or Halozyme Therapeutics, Inc.?
Merck & Co., Inc. vs Dynavax Technologies Corporation: Examining Key Revenue Metrics
Who Generates More Revenue? Regeneron Pharmaceuticals, Inc. or Travere Therapeutics, Inc.
Genmab A/S or Travere Therapeutics, Inc.: Who Leads in Yearly Revenue?
Corcept Therapeutics Incorporated and Travere Therapeutics, Inc.: A Comprehensive Revenue Analysis
Revenue Insights: Cytokinetics, Incorporated and Travere Therapeutics, Inc. Performance Compared
Revenue Showdown: TG Therapeutics, Inc. vs Travere Therapeutics, Inc.
Who Generates More Revenue? Dynavax Technologies Corporation or Travere Therapeutics, Inc.
Who Generates More Revenue? Travere Therapeutics, Inc. or Celldex Therapeutics, Inc.
Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis